|
| 1 |
Effect of Afatinib for Lung Cancer on Papillary Thyroid Carcinoma
Sang Hwon Cho, Jin Seok Lee, Hyeok Jun Yun, Yong Sang Lee, Hang-Seok Chang
|
|
| 2 |
EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation
Sehhoon Park, Bo Mi Ku, Hyun Ae Jung, Jong-Mu Sun, Jin Seok Ahn, Se-Hoon Lee, Keunchil Park, Myung-Ju Ahn
Cancer Res Treat.2020;52(4):1288-1290. Published online 2020 June 22
DOI: http://dx.doi.org/10.4143/crt.2020.278
|
|
| 3 |
Olmutinib Induced Lichen Planus Like Eruption
Seung Hwan Oh, Hyun Jeong Byun, Se Jin Oh, Ji-Young Jun, Ji-Hye Park, Jong Hee Lee, Dong-Youn Lee, Joo-Heung Lee, Jun-Mo Yang
Ann Dermatol.2018;30(4):451-453. Published online 2018 June 27
DOI: http://dx.doi.org/10.5021/ad.2018.30.4.451
|
|
| 4 |
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Youngjoo Lee, Ki Hyeong Lee, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Yun Jung Go, Jin Soo Lee, Ji-Youn Han
Cancer Res Treat.2017;49(4):1001-1011. Published online 2017 January 13
DOI: http://dx.doi.org/10.4143/crt.2016.546
|
|
| 5 |
Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status
Youngjoo Lee, Ji-Youn Han, Sung Ho Moon, Byung-Ho Nam, Kun Young Lim, Geon Kook Lee, Heung Tae Kim, Tak Yun, Hye Jin An, Jin Soo Lee
Cancer Res Treat.2017;49(4):981-989. Published online 2017 January 6
DOI: http://dx.doi.org/10.4143/crt.2016.522
|
|
| 6 |
Clinical Characteristics and Continued Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Administration in EGFR-mutated Non-Small Cell Lung Cancer with Skeletal Metastasis
Sook-Hee Hong, Yeon-Sil Kim, Ji Eun Lee, In-ho Kim, Seung Joon Kim, Daehee Han, Ie Ryung Yoo, Yang-Guk Chung, Young-Hoon Kim, Kyo-Young Lee, Jin-Hyoung Kang
Cancer Res Treat.2016;48(3):1110-1119. Published online 2016 January 6
DOI: http://dx.doi.org/10.4143/crt.2015.289
|
|
| 7 |
The Prognostic Value of the Tumor Shrinkage Rate for Progression-Free Survival in Patients with Non-Small Cell Lung Cancer Receiving Gefitinib
Dong Il Park, Sun Young Kim, Ju Ock Kim, Sung Soo Jung, Hee Sun Park, Jae Young Moon, Chae Uk Chung, Song Soo Kim, Jae Hee Seo, Jeong Eun Lee
|
|
| 8 |
Systemic Nocardiosis Mimicking Disease Flare-up after Discontinuation of Gefitinib in a Patient with EGFR-Mutant Lung Cancer
Mihong Choi, Youngjoo Lee, Sang Hyun Hwang, Jin Soo Lee
|
|
| 9 |
Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
Jae Cheol Lee, Seung Hun Jang, Kye Young Lee, Young-Chul Kim
|
|
| 10 |
Mechanisms of Acquired Resistance to Epidermal Growth Factor Receptor Inhibitors and Overcoming Strategies in Lung Cancer
Chang-Min Choi, Jae Cheol Lee
J Lung Cancer.2012;11(2):59-65. Published online 2012 December 27
DOI: http://dx.doi.org/10.6058/jlc.2012.11.2.59
|
|
| 11 |
EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
Minkyu Jung, Byoung Chul Cho, Chul Ho Lee, Hyung Soon Park, Young Ae Kang, Se Kyu Kim, Joon Chang, Dae Jun Kim, Sun Young Rha, Joo Hang Kim, Ji Hyun Lee
Yonsei Med J.2012;53(6):1128-1135. Published online 2012 October 5
DOI: http://dx.doi.org/10.3349/ymj.2012.53.6.1128
|
|
